REAX Form 144: Insider notice to sell 2,641 RSU shares valued $12,940
Form 144 filed for Real Brokerage Inc (REAX) reports a proposed sale of 2,641 common shares by an insider that were acquired as restricted stock units on 09/17/2025.
Rhea-AI Filing Summary
Form 144 filed for Real Brokerage Inc (REAX) reports a proposed sale of 2,641 common shares by an insider that were acquired as restricted stock units on 09/17/2025. The filing lists the broker as Morgan Stanley Smith Barney LLC and indicates an aggregate market value of $12,940.90 for the proposed sale, with the sale planned on 09/22/2025 on NASDAQ. The filer also disclosed two 10b5-1 sales by the same person in the past three months totaling 50,654 shares for gross proceeds of $253,821.90. The filer represents they have no undisclosed material information and references a 10b5-1 trading plan where applicable.
Positive
- None.
Negative
- The filer discloses recent insider sales totaling 50,654 shares in the past three months for gross proceeds of $253,821.90
- The proposed sale includes 2,641 RSU shares to be sold shortly after grant date, which increases insider share turnover
Insights
TL;DR: Insider plans to sell a small grant of RSUs; prior 10b5-1 sales totaled 50,654 shares.
The filing documents a routine Form 144 notice for 2,641 common shares acquired as restricted stock units on 09/17/2025, to be sold via Morgan Stanley on 09/22/2025 at an aggregate market value of $12,940.90. The notice also discloses two prior 10b5-1 sales by the same individual on 08/25/2025 and 09/16/2025 totaling 50,654 shares and $253,821.90 in gross proceeds. This is a standard insider sale disclosure; it confirms reliance on applicable trading-plan representations but does not include company operational or financial data.
TL;DR: Filing shows compliance with Rule 144 and disclosure of recent 10b5-1 sales; no operational details provided.
The notice appears focused on regulatory compliance: specifying the source of the shares (RSUs granted by the issuer), broker details, and recent aggregated sales subject to 10b5-1 plans. The signer attests to no undisclosed material adverse information. The document contains no additional governance actions, executive departures, or material corporate events.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 for REAX report?
Who is the broker handling the sale listed on the Form 144?
Were there any recent insider sales disclosed in this filing for REAX?
What is the aggregate market value of the proposed sale on the Form 144?
Does the filer assert they possess undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.